Tennessee SB 1020: Opioids - As introduced, requires a prescribing healthcare practitioner to discuss certain risks associated with a prescribed Schedule II controlled substance prior to an initial prescription and following the third prescription of the drug during a course of treatment; requires the practitioner to document the discussion of such risks in the patient’s medical record. - Amends TCA Title 53 and Title 63.

Status: Assigned to General Subcommittee of Senate Health and Welfare Committee (as of 2023-02-22)

State: Tennessee · Session: 113 · Bill: SB 1020

Subjects: Opioids

Sponsors: Campbell

View Tennessee SB 1020 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.